Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
A quick guide to the year-end tax forms required for ETFs and tips to ensure correct reporting on your return.
24,251 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Fans dream of owning a piece of their favorite team. When a high-profile artist says they want a real stake rather th...
As Intuitive Surgical prepares to report earnings, investors weigh the risk/reward of buying the stock now. This guid...
As 2026 unfolds, a value-led rotation is drawing fresh money into the Vanguard Value ETF (VTV). With inflation coolin...
The International Energy Agency has authorized an unprecedented emergency release of 400 million barrels to blunt ene...
When a prominent executive questions a public pledge with a personal twist, investors and workers feel the reverberat...
Ripple’s XRP remains the sole top‑five crypto in the red over the last 90 days, even as broader markets rebound. Here...
A Friday announce could insert Marvell into the S&P 500 after a dramatic stock surge. The company's market cap dwarfs...
As the space economy expands, investors face a big question: spacex rocket lab: which stock deserves a place in a gro...
Global markets weigh climate risk as a likely Super El Niño could boost temperatures in 2027. This stock trader’s gui...
Michael Burry has added a Micron short, expanding a wager that AI-driven chip stocks may soon pull back. The move com...
An unusual trading day put Lucid Group in the spotlight after rumors swirled about bankruptcy or going private. Learn...